MedTrace Logo

SecuraTM ICD Clinical Evaluation Study

NCT00526227 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2025-07-02

Study results available
· View outcomes & findings →

Summary

The purpose of the Secura clinical study is to evaluate the overall system safety and clinical performance of the Secura DR Implantable Cardioverter Defibrillator (ICD)

Conditions

  • Tachyarrhythmias

Interventions

DEVICE

Secura ICD

Secura Implantable Cardioverter Defibrillator (ICD) will be implanted

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Secura Clinical Study Team · Medtronic Cardiac Rhythm and Heart Failure

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-12-31
Completion
2008-10-31

Countries

  • Austria
  • Finland
  • Germany
  • Greece
  • Netherlands
  • Saudi Arabia
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00526227 on ClinicalTrials.gov